{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:17:35Z","timestamp":1760235455761,"version":"build-2065373602"},"reference-count":20,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s550126","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:50:13Z","timestamp":1760165413000},"page":"9227-9234","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects"],"prefix":"10.2147","volume":"Volume 19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3973-047X","authenticated-orcid":true,"given":"Jaegu","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-9158","authenticated-orcid":true,"given":"Sungyeun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-7225","authenticated-orcid":true,"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1713-9194","authenticated-orcid":true,"given":"SeungHwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/08830185.2021.1884248","volume":"41","author":"Que","year":"2022","journal-title":"Int Rev Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/j.bbmt.2018.12.756","volume":"25","author":"Frey","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.immuni.2016.10.026","volume":"45","author":"Becher","year":"2016","journal-title":"Immunity"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"eabg9873","DOI":"10.1126\/sciimmunol.abg9873","volume":"6","author":"Thwaites","year":"2021","journal-title":"Sci Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"AB229","DOI":"10.1016\/j.jaci.2012.12.1483","volume":"131","author":"Molfino","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e007709","DOI":"10.1136\/bmjopen-2015-007709","volume":"6","author":"Molfino","year":"2016","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/thoraxjnl-2022-218744","volume":"78","author":"Temesgen","year":"2023","journal-title":"Thorax"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"10318","DOI":"10.1182\/blood-2022-167688","volume":"140","author":"Oluwole","year":"2022","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1182\/blood-2019-131181","volume":"134","author":"Patnaik","year":"2019","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00280-013-2240-8","volume":"72","author":"Doi","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1200\/JCO.2003.12.109","volume":"21","author":"Leyland-Jones","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13318-017-0430-1","volume":"43","author":"Reijers","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"110909","DOI":"10.1016\/j.isci.2024.110909","volume":"27","author":"Panigrahi","year":"2024","journal-title":"Iscience"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jcph.1545","volume":"60","author":"An","year":"2020","journal-title":"J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1182\/blood-2009-05-155689","volume":"113","author":"Uchida","year":"2009","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/antib8040056","volume":"8","author":"Thomas","year":"2019","journal-title":"Antibodies"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5414\/cp203235","volume":"56","author":"Tanaka","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.clim.2010.02.017","volume":"135","author":"Carey","year":"2010","journal-title":"Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1183\/09059180.00001311","volume":"20","author":"Borie","year":"2011","journal-title":"Eur Respir Rev"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/107811","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/107811","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:50:14Z","timestamp":1760165414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pharmacokinetics-safety-and-tolerability-of-intravenous-lenzilumab-an--peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2147\/dddt.s550126","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}